141 related articles for article (PubMed ID: 12107672)
1. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes.
Pelz RK; Lipsett PA; Swoboda SM; Diener-West M; Powe NR; Brower RG; Perl TM; Hammond JM; Hendrix CW
Intensive Care Med; 2002 Jun; 28(6):692-7. PubMed ID: 12107672
[TBL] [Abstract][Full Text] [Related]
2. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study.
McNeil SA; Malani PN; Chenoweth CE; Fontana RJ; Magee JC; Punch JD; Mackin ML; Kauffman CA
Clin Infect Dis; 2006 Jan; 42(2):195-203. PubMed ID: 16355329
[TBL] [Abstract][Full Text] [Related]
3. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococcus: relationships with antibiotic use and cost drivers.
Mauldin PD; Salgado CD; Durkalski VL; Bosso JA
Ann Pharmacother; 2008 Mar; 42(3):317-26. PubMed ID: 18285560
[TBL] [Abstract][Full Text] [Related]
4. Vancomycin-resistant Enterococcus colonization in the intensive care unit: clinical outcomes and attributable costs of hospitalization.
Jung E; Byun S; Lee H; Moon SY; Lee H
Am J Infect Control; 2014 Oct; 42(10):1062-6. PubMed ID: 25278394
[TBL] [Abstract][Full Text] [Related]
5. Role of environmental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit.
MartÃnez JA; Ruthazer R; Hansjosten K; Barefoot L; Snydman DR
Arch Intern Med; 2003 Sep; 163(16):1905-12. PubMed ID: 12963563
[TBL] [Abstract][Full Text] [Related]
6. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital.
Warren DK; Quadir WW; Hollenbeak CS; Elward AM; Cox MJ; Fraser VJ
Crit Care Med; 2006 Aug; 34(8):2084-9. PubMed ID: 16763511
[TBL] [Abstract][Full Text] [Related]
7. Cost of Gram-negative resistance.
Evans HL; Lefrak SN; Lyman J; Smith RL; Chong TW; McElearney ST; Schulman AR; Hughes MG; Raymond DP; Pruett TL; Sawyer RG
Crit Care Med; 2007 Jan; 35(1):89-95. PubMed ID: 17110877
[TBL] [Abstract][Full Text] [Related]
8. Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.
Chou YY; Lin TY; Lin JC; Wang NC; Peng MY; Chang FY
J Microbiol Immunol Infect; 2008 Apr; 41(2):124-9. PubMed ID: 18473099
[TBL] [Abstract][Full Text] [Related]
9. Outbreak of vancomycin-resistant Enterococcus spp. in an Italian general intensive care unit.
Peta M; Carretto E; Barbarini D; Zamperoni A; Carnevale L; Perversi L; Pagani M; Bonora MG; Fontana R; Marone P; Langer M
Clin Microbiol Infect; 2006 Feb; 12(2):163-9. PubMed ID: 16441455
[TBL] [Abstract][Full Text] [Related]
10. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center.
Warren DK; Shukla SJ; Olsen MA; Kollef MH; Hollenbeak CS; Cox MJ; Cohen MM; Fraser VJ
Crit Care Med; 2003 May; 31(5):1312-7. PubMed ID: 12771596
[TBL] [Abstract][Full Text] [Related]
11. Enterococcal bacteraemia: factors influencing mortality, length of stay and costs of hospitalization.
Cheah AL; Spelman T; Liew D; Peel T; Howden BP; Spelman D; Grayson ML; Nation RL; Kong DC
Clin Microbiol Infect; 2013 Apr; 19(4):E181-9. PubMed ID: 23398607
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammatory response syndrome in adult patients with nosocomial bloodstream infections due to enterococci.
Bar K; Wisplinghoff H; Wenzel RP; Bearman GM; Edmond MB
BMC Infect Dis; 2006 Sep; 6():145. PubMed ID: 17002792
[TBL] [Abstract][Full Text] [Related]
13. Acquisition of vancomycin-resistant enterococci during scheduled antimicrobial rotation in an intensive care unit.
Puzniak LA; Mayfield J; Leet T; Kollef M; Mundy LM
Clin Infect Dis; 2001 Jul; 33(2):151-7. PubMed ID: 11418873
[TBL] [Abstract][Full Text] [Related]
14. Cost of intensive care unit-acquired bloodstream infections.
Laupland KB; Lee H; Gregson DB; Manns BJ
J Hosp Infect; 2006 Jun; 63(2):124-32. PubMed ID: 16621137
[TBL] [Abstract][Full Text] [Related]
15. Economic analysis of vancomycin-resistant enterococci at a Canadian hospital: assessing attributable cost and length of stay.
Lloyd-Smith P; Younger J; Lloyd-Smith E; Green H; Leung V; Romney MG
J Hosp Infect; 2013 Sep; 85(1):54-9. PubMed ID: 23920443
[TBL] [Abstract][Full Text] [Related]
16. Consequences of vancomycin-resistant Enterococcus in liver transplant recipients: a matched control study.
Gearhart M; Martin J; Rudich S; Thomas M; Wetzel D; Solomkin J; Hanaway MJ; Aranda-Michel J; Weber F; Trumball L; Bass M; Zavala E; Steve Woodle E; Buell JF
Clin Transplant; 2005 Dec; 19(6):711-6. PubMed ID: 16313314
[TBL] [Abstract][Full Text] [Related]
17. Investigation of the prevalence of patients co-colonized or infected with methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in China: a hospital-based study.
Wang Z; Cao B; Liu YM; Gu L; Wang C
Chin Med J (Engl); 2009 Jun; 122(11):1283-8. PubMed ID: 19567138
[TBL] [Abstract][Full Text] [Related]
18. Clinical characteristics and outcomes of surgical patients with vancomycin-resistant enterococcal infections.
Joels CS; Matthews BD; Sigmon LB; Hasan R; Lohr CE; Kercher KW; Norton J; Sing RF; Heniford BT
Am Surg; 2003 Jun; 69(6):514-9. PubMed ID: 12852510
[TBL] [Abstract][Full Text] [Related]
19. Tolerance of vancomycin for surgical prophylaxis in patients undergoing cardiac surgery and incidence of vancomycin-resistant enterococcus colonization.
Kachroo S; Dao T; Zabaneh F; Reiter M; Larocco MT; Gentry LO; Garey KW
Ann Pharmacother; 2006 Mar; 40(3):381-5. PubMed ID: 16478809
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-resistant enterococci bacteremia: risk factors for mortality and influence of antimicrobial therapy on clinical outcome.
Han SH; Chin BS; Lee HS; Jeong SJ; Choi HK; Kim CO; Yong D; Choi JY; Song YG; Lee K; Kim JM
J Infect; 2009 Mar; 58(3):182-90. PubMed ID: 19233476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
